Moneycontrol NewsIsrael-based Teva Pharmaceutical Industries on Wednesday warned Mylan of “significant damages” if it goes ahead and launches generic version of Copaxone 40mg/ml prior to resolution of the pending patent litigation.“Any launch by Mylan of a generic version of Copaxone 40mg/ml (glatiramer acetate) prior to final resolution of the pending patent appeals and other patent litigation should be considered an “at-risk” launch, which could subject Mylan to significant damages among other remedies,” Teva said in a statement reacting to Mylan’s approval of generic glatiramer acetate.Teva said it will do its best to defend its patent claims over the Copaxone 40mg/ml version and is prepared to face generic competition.Close Teva will be appealing against the earlier orders by Patent Trial Appeal Board and US District Court for the District of Delaware that came against some of the patent it held. The company also brought a suit against five … [Read more...] about Teva warns Mylan of ‘significant damages’ if it goes ahead with the launch of Copaxone 40mg copy
Moneycontrol NewsMylan on Thursday said it has launched the generic version of Israel-based Teva multiple sclerosis (MS) drug Copaxone 40 mg/mL for 3-times-a-week injection in US market.The launch comes as analysts were debating whether Mylan should wait for the outcome on the pending patent ligation or it will go ahead and launch “at risk”.Mylan will have to pay millions of dollars in damages to Teva if it fails to invalidate the remaining patents held by the Israeli drug maker.Close Teva has already warned Mylan of “significant damages” if it goes ahead and launches the generic version of Copaxone 40mg/ml prior to the resolution of the pending patent litigation. related news Fortis to explore legal recourse after SC issues contempt notice in Singh bros case 35% Mutual Fund equity assets stayed invested for over 2 years: AMFI data Tata Motors ties up with Lithium Urban for EV segment Teva said it will be appealing against the earlier orders by Patent … [Read more...] about Mylan launches copy of Copaxone 40 mg even as patent litigation is on
Natco Pharma said it plans to utilise the cash flows generated by the launch of generic versions of Teva’s multiple sclerosis Copaxone 20 mg/ml and 40 mg/ml by its partner Mylan in US towards strengthening balance sheet and investing on business expansion.“It makes our balance sheet much stronger than we are at the moment and gives us ability to spend more aggressively on interesting things,” said Rajeev Nannapaneni, the Vice-Chairman and Chief Executive Officer in an exclusive interview to Moneycontrol over phone.Nannapaneni declined to give specific details on the company’s future plans, but said he would be focusing on expanding company’s toehold in Indian formulation business among other things.Close Shares of Natco rose as much as 30 percent in the last three trading sessions from the day of the USFDA approval of two Copaxone copies. related news Fortis to explore legal recourse after SC issues contempt notice in Singh bros case 35% … [Read more...] about Profits from Copaxone generics to help strengthen balance sheet, expansion: Natco CEO
“Yesterday, I left my wallet at home,” says Chancelor Bennett, aka Chance the Rapper. It’s 9 p.m. on a fall evening at a Chicago recording studio, and he and his bandmates are packing up for the night. Four days from now, they will put on their biggest show of the year, at the city’s United Center. advertisement advertisement Bennett sits next to me in high-waisted track pants and a fitted tee. He admits to feeling a little overwhelmed by having a new baby at home and a new tour to prepare for, and yesterday was proof. He had taken his 4-year-old daughter, Kensli, to Dunkin’ for a rare treat before school. It was the first day all week that he had been able to do morning drop-off, and he’d wanted it to feel special. She picked out a glistening, sprinkle-topped chocolate doughnut, and he realized his pocket was empty. “It’s just a crazy letdown for a child,” he says, shaking his head, clearly still unable to forgive … [Read more...] about Chance the Rapper has nothing to fear but FOMO itself
Manhattan is the densest area in the U.S., and one of the densest in the world. That’s because while there are 2 million people who reside on the island, that number doubles to 4 million during the workday, when people from the surrounding counties and states pour into the city. advertisement A new interactive by the data viz designer and researcher Justin Fung shows this remarkable mini-migration over the course of a single day. Using a mix of data from the 2010 Census, the MTA’s turnstile database, and a previous NYU study, Fung was able to create block-by-block estimates for the population of Manhattan at any given time. Fung first became interested in compiling this kind of data set after Hurricane Sandy, when he began to wonder if there are good estimates for how many people are actually in Manhattan at particular times, which would help with emergency planning. He was in graduate school at Columbia University at the time for operations research, and created … [Read more...] about This Gorgeous Viz Reveals The Invisible Heartbeat Of N.Y.C.